George A Poultsides
Overview
Explore the profile of George A Poultsides including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
343
Citations
7950
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serenari M, Berti D, Rivera B, Newhook T, Kristjanpoller W, Ruzzenente A, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40050485
Background: Gallbladder cancer (GBC) has a poor prognosis, particularly in advanced stages, with surgery often offering limited survival benefit. This study aimed to identify risk factors for futile surgery (FS),...
2.
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, et al.
Eur J Surg Oncol
. 2025 Mar;
51(6):109723.
PMID: 40023021
Background: Severe postoperative complications still occur following hepatectomy among patients with hepatocellular carcinoma (HCC). There is a need to identify high-risk patients for severe complications to enhance patient safety. We...
3.
Ayala C, Sathe A, Bai X, Grimes S, Shen J, Poultsides G, et al.
Front Genet
. 2025 Feb;
16:1536982.
PMID: 40018643
Introduction: Appendiceal mucinous neoplasms (AMN) are rare tumors of the gastrointestinal tract. They metastasize with widespread abdominal dissemination leading to pseudomyxoma peritonei (PMP), a disease with poor prognosis. There are...
4.
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, et al.
Eur J Surg Oncol
. 2025 Feb;
51(6):109683.
PMID: 40009916
Background: The association between preoperative imaging and postoperative pathological tumor size disparity, and cancer-specific survival (CSS) among patients undergoing hepatectomy for hepatocellular carcinoma (HCC) remains unclear. We sought to evaluate...
5.
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, et al.
J Gastrointest Surg
. 2025 Feb;
29(4):101984.
PMID: 39922533
Background: The albumin-bilirubin (ALBI) score, used for predicting outcomes after hepatocellular carcinoma (HCC) resection, does not directly capture liver cell damage or biliary obstruction. Gamma-glutamyl transferase (GGT), which reflects hepatic...
6.
Lu J, Wang F, Zhang W, Ren Y, Yang T, Ratti F, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2499-2500.
PMID: 39863801
No abstract available.
7.
Lu J, Wang F, Zhang W, Ren Y, Yang T, Ratti F, et al.
Ann Surg Oncol
. 2024 Dec;
32(4):2446-2455.
PMID: 39730966
Background: We sought to define whether and how hepatic ischemia/reperfusion (I/R) as manifested by perioperative aspartate aminotransferase (AST) and alanine aminotransaminase (ALT) levels impact long-term outcomes after curative-intent resection of...
8.
Ahmad M, Javadi C, Chang J, Forgo E, Delitto D, Dua M, et al.
Ann Surg
. 2024 Dec;
PMID: 39676639
Objective: To examine the optimal method of assessing response to neoadjuvant therapy (NAT) in operable pancreatic ductal adenocarcinoma (PDAC) patients. Summary Of Background Data: PDAC response to NAT is measured...
9.
Akabane M, Kawashima J, Woldesenbet S, Macedo A, Cauchy F, Shen F, et al.
Ann Surg Oncol
. 2024 Dec;
32(2):1112-1113.
PMID: 39638992
No abstract available.
10.
Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma
Akabane M, Kawashima J, Woldesenbet S, Altaf A, Cauchy F, Aucejo F, et al.
J Gastrointest Surg
. 2024 Nov;
29(2):101903.
PMID: 39613250
Background: The effect of "time to surgery (TTS)" on outcomes for curative-intent hepatectomy of hepatocellular carcinoma (HCC) remains debated. The interaction between tumor burden score (TBS) and TTS remains unclear....